Skip to main content

ABEONA THERAPEUTICS INC.

Data quality: 100%
ABEO
Nasdaq Manufacturing Chemicals
$4.91
▼ $0.21 (-4.10%)
Mkt Cap: 294.66 M
Price
$5.17
Mkt Cap
294.66 M
Day Range
52-Week Range
Volume
Open —
50D / 200D Avg
50D / 200D Avg

Quick Summary

Key Takeaways

Revenue grew 18.02% annually over 5 years — strong growth
ROE of 42.52% indicates high profitability
Net margin of 1223.08% shows strong profitability
Debt/Equity of 0.12 — conservative balance sheet
Negative free cash flow of -84.30 M
P/E of 4.14 — trading at a low valuation

Growth

Revenue Growth (5Y)
18.02%
Above sector avg (1.82%)
Revenue (1Y)66.29%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
42.52%
Above sector avg (-53.34%)
ROIC-42.47%
Net Margin1223.08%
Op. Margin-1536.91%

Safety

Debt / Equity
0.12
Below sector avg (0.31)
Current Ratio9.74
Interest Coverage-23.92

Valuation

PE (TTM|2027)
4.14 | 21.54
Above sector avg (-1.47)
P/B Ratio1.72
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E 4.1 -1.5
P/B 1.7 1.6
ROE % 42.5 -53.3
Net Margin % 1223.1 -41.5
Rev Growth 5Y % 18.0 1.8
D/E 0.1 0.3

Analyst Price Target

7 analysts
Buy
Current
$4.91
+298.6%
Target
$19.57
$13.00
$20.00
$28.00
Forecast
Forward P/E 20.46
Forward EPS $0.24
Est. Revenue 145.72 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 $0.24
-$0.21 – $0.63
145.72 M 3
FY2026 -$0.91
-$1.05 – -$0.79
66.43 M 3

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.37 -$0.37 +2.2%
Q32025 -$0.34 -$0.11 +68.5%
Q22025 -$0.39 -$0.47 -19.0%
Q12025 -$0.35 -$0.24 +32.2%

ETFs Holding This Stock

SURI logo SURI Simplify Propel Opportunities ETF
4.27% weight
DTSGX DTSGX
0.03% weight
WSMGX WSMGX
0.03% weight
IRSSX IRSSX
0.01% weight
IIRSX IIRSX
0.01% weight
IRSIX IRSIX
0.01% weight
IRCIX IRCIX
0.01% weight
VVICX VVICX
0.01% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y) 66.29% Revenue Growth (3Y) 28.95%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 18.02% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5.82 M Net Income (TTM) 71.18 M
ROE 42.52% ROA 29.83%
Gross Margin N/A Operating Margin -1536.91%
Net Margin 1223.08% Free Cash Flow (TTM) -84.30 M
ROIC -42.47% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.12 Current Ratio 9.74
Interest Coverage -23.92 Asset Turnover 0.02
Working Capital 193.95 M Tangible Book Value 171.23 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 4.14 Forward P/E N/A
P/B Ratio 1.72 P/S Ratio 50.63
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -28.61%
Market Cap 294.66 M Enterprise Value 231.53 M
Per Share
EPS (Diluted TTM) 1.01 Revenue / Share 0.10
FCF / Share -1.48 OCF / Share -1.34
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 137.03% FCF Conversion -118.43%
SBC-Adj. FCF -94.33 M Growth Momentum 48.27

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5.82 M 3.50 M 3.50 M 1.41 M 3.00 M
Net Income 71.18 M -63.73 M -54.19 M -39.70 M -84.94 M
EPS (Diluted) 1.01 -1.55 -2.53
Gross Profit
Operating Income -89.45 M -64.21 M -47.14 M -50.92 M -89.84 M
EBITDA
R&D Expenses 26.81 M 34.36 M 31.09 M 28.97 M 34.33 M
SG&A Expenses 65.03 M
D&A 2.55 M 2.00 M 2.29 M 3.09 M 3.25 M
Interest Expense 3.74 M 4.21 M 418,000.0 736,000.0 3.67 M
Income Tax 100,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 219.57 M 108.93 M 64.00 M 64.21 M 79.59 M
Total Liabilities 60.35 M 64.90 M 49.18 M 37.45 M 28.21 M
Shareholders' Equity 159.22 M 44.03 M 14.83 M 26.76 M 51.38 M
Total Debt 20.04 M 18.96 M
Cash & Equivalents 78.44 M 23.36 M 14.47 M 14.22 M 32.94 M
Current Assets 204.91 M 100.85 M 55.74 M 53.10 M 55.40 M
Current Liabilities 29.57 M 16.59 M 13.42 M 7.78 M 16.62 M